Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CVLT | PCTY |
|---|---|---|
| Price | $154.98 | $146.16 |
| Change today | ▲ 0.81% | ▼ 0.83% |
| Market cap | $6.42B | $7.75B |
| Return, 3 months | +5.5% | +26.9% |
| Return, year to date | +23.6% | -4.2% |
| Return, 1 year | -7.9% | -4.6% |
| P/E (TTM) | 99.3 | 29.7 |
| P/B | 123.4 | 6.3 |
| P/E percentile vs own 5y | 72nd | 12th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +11.4% | +11.0% |
| Net profit growth (YoY) | -10.0% | +24.1% |
| Gross margin | 81.1% | 69.2% |
| Operating margin | 9.0% | 21.8% |
| Net margin | 5.6% | 15.2% |
| Return on equity | 32.8% | 22.0% |
| Analyst target vs. price | +7.5% | +20.1% |
| Analyst buy share | 73% | 88% |
| RSI (14) | 64 | 52 |
| 30-day volatility | 42.2% | 30.2% |
| Max drawdown, 1 year | -61.1% | -42.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
